Human Genome Epidemiology Literature Finder
Records 1 - 22 (of 22 Records) |
Query Trace: Carcinoma and MUT[original query] |
---|
Functional variant in the 3'-untranslated region of Toll-like receptor 4 is associated with nasopharyngeal carcinoma risk. Cancer biology & therapy 2006 Oct 5 (10): 1285-91. Song Chang, Chen Li-Zheng, Zhang Ru-Hua, Yu Xing-Juan, Zeng Yi-X |
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma. European journal of cancer (Oxford, England : 1990) 2014 Dec 50 (18): 3145-52. Milowsky Matthew I, Dittrich Christian, Durán Ignacio, Jagdev Satinder, Millard Frederick E, Sweeney Christopher J, Bajorin Dean, Cerbone Linda, Quinn David I, Stadler Walter M, Rosenberg Jonathan E, Lochheed Melissa, Sen Paramita, Squires Matthew, Shi Michael, Sternberg Cora |
Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas. Lung cancer (Amsterdam, Netherlands) 2017 Nov 113 93-101. Lococo Filippo, Torricelli Federica, Rossi Giulio, Alifano Marco, Damotte Diane, Rapicetta Cristian, Tamagnini Ione, Cavazza Alberto, Piana Simonetta, Galeone Carla, Paci Massimiliano, Ciarrocchi Aless |
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition. Journal of gastrointestinal oncology 2018 Aug 9 (4): 610-617. Fabrizio David A, George Thomas J, Dunne Richard F, Frampton Garrett, Sun James, Gowen Kyle, Kennedy Mark, Greenbowe Joel, Schrock Alexa B, Hezel Aram F, Ross Jeffrey S, Stephens Phillip J, Ali Siraj M, Miller Vincent A, Fakih Marwan, Klempner Samuel |
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Molecular cancer 2018 Apr 17 (1): 81. Liu Liang, Ruiz Jimmy, O'Neill Stacey S, Grant Stefan C, Petty W Jeffrey, Yang Meng, Chen Kexin, Topaloglu Umit, Pasche Boris, Zhang W |
Interpretation of somatic POLE mutations in endometrial carcinoma. The Journal of pathology 2019 12 250 (3): 323-335. León-Castillo Alicia, Britton Heidi, McConechy Melissa K, McAlpine Jessica N, Nout Remi, Kommoss Stefan, Brucker Sara Y, Carlson Joseph W, Epstein Elisabeth, Rau Tilman T, Bosse Tjalling, Church David N, Gilks C Bla |
Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Jun . Sun Xiangjie, Zuo Ke, Yao Qianlan, Zhou Shuling, Shui Ruohong, Xu Xiaoli, Bi Rui, Yu Baohua, Cheng Yufan, Tu Xiaoyu, Lu Hongfen, Yang Went |
CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 5 33 (12): 2614-2625. Williams Erik A, Montesion Meagan, Sharaf Radwa, Corines James, Patel Parth J, Gillespie Brendan J, Pavlick Dean C, Sokol Ethan S, Alexander Brian M, Williams Kevin Jon, Elvin Julia A, Ross Jeffrey S, Ramkissoon Shakti H, Hemmerich Amanda C, Tse Julie Y, Mochel Mark |
Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 2020 10 41 (1): 192-203. Wong Ching Ngar, Fessas Petros, Dominy Kathy, Mauri Francesco A, Kaneko Takahiro, Parcq Persephone Du, Khorashad Jamshid, Toniutto Pierluigi, Goldin Robert D, Avellini Claudio, Pinato David |
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study). ESMO open 2021 7 6 (4): 100212. Perez-Fidalgo J A, Cortés A, Guerra E, García Y, Iglesias M, Bohn Sarmiento U, Calvo García E, Manso Sánchez L, Santaballa A, Oaknin A, Redondo A, Rubio M J, González-Martín |
Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 2021 3 11 (10): 4585-4598. Lin Jianzhen, Cao Yinghao, Yang Xu, Li Guangyu, Shi Yang, Wang Dongxu, Long Junyu, Song Yang, Mao Jinzhu, Xie Fucun, Bai Yi, Zhang Lei, Yang Xiaobo, Wan Xueshuai, Wang Anqiang, Guan Mei, Zhao Lin, Hu Ke, Pan Jie, Huo Li, Lu Xin, Mao Yilei, Sang Xinting, Zhang Henghui, Wang Kai, Wang Xiaoyue, Zhao Hait |
Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma. Frontiers in genetics 2021 12 12 756506. Peng Ying-Peng, Wang Rong, Liu Qiao-Dan, Xu Xi-Wei, Wei Wei, Huang Xiao-Tao, Peng Xiao-Mou, Liu Zhi-Ga |
Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11). Clinical cancer research : an official journal of the American Association for Cancer Research 2022 7 28 (19): 4240-4247. Jung Hyun Ae, Park Keon-Uk, Cho Sanghee, Lim Jinyeong, Lee Keun-Wook, Hong Min Hee, Yun Tak, An Ho Jung, Park Woong-Yang, Pereira Sergio, Ock Chan-Young, Keam Bhums |
Prognostic significance of PD-L1 expression and CD8 TILs density for disease-free survival in surgically resected lung squamous cell carcinoma: a retrospective study. Journal of thoracic disease 2022 7 14 (6): 2224-2234. Cheng Xiaomin, Wang Lei, Zhang Zhem |
Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2022 3 42 (1): 43-53. Haag Jennifer G, Wolsky Rebecca J, Moroney Marisa R, Sheren Jamie, Sheeder Jeanelle, Bitler Benjamin G, Corr Bradley |
Non-Exonuclease Domain POLE Mutations Associated with Immunotherapy Benefit. The oncologist 2022 3 27 (3): 159-162. Dong Sharlene, Zakaria Heba, Hsiehchen Dav |
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features. Current oncology (Toronto, Ont.) 2022 11 29 (11): 8638-8649. Vlachostergios Panagiotis J, Tamposis Ioannis A, Anagnostou Maria, Papathanassiou Maria, Mitrakas Lampros, Zachos Ioannis, Thodou Eleni, Samara Maria, Tzortzis Vassili |
Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carcinoma. Neoplasma 2022 Oct . Chen Gang, Zhu Yong-Jun, Chen Ji, Miao Feng, Wu Ning, Song Yang, Mao Bei-Bei, Wang Sheng-Zhou, Xu Fei, Chen Zhi-Mi |
A genomic mutation spectrum of collecting duct carcinoma in the Chinese population. BMC medical genomics 2022 1 15 (1): 1. Zhang Huaru, Lu Xiaojun, Huang Gang, Hua Meimian, Zhang Wenhui, Wang Tao, Huang Liqun, Wang Ziwei, Chen Qing, Li Jing, Yang Qing, Yang Guoshe |
Mutational pattern off homologous recombination repair (HRR)-related genes in upper tract urothelial carcinoma. Cancer medicine 2023 6 . Kaiwei Yang, Wei Yu, Huanhuan Liu, Feng Lou, Shanbo Cao, Huina Wang, Zhisong |
Tumor Mutational Burden as a Predictor of Survival With Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 2 . Wildsmith Sophie, Li Weimin, Wu Song, Stewart Ross, Morsli Nassim, Raja Rajiv, Zhang Qu, Ye Jiabu, He Philip, Shetty Jagdish, Yovine Alejandro, Holoweckyj Nicholas, Real Katia, Walker Jill, Wrona Magdalena, de Los Reyes Melissa, Barker Craig, Whiteley Jessica, Haddad Robert, Licitra Lisa, Ferris Robert, Fayette Jérôme, Zandberg Dan P, Siu Lillian L, Mesía Rica |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: